Secukinumab, a Monoclonal Antibody to Interleukin-17A, Provides Significant and Sustained Inhibition of Joint Structural Damage in Active Psoriatic Arthritis Regardless of Prior TNF Inhibitors or Concomitant Methotrexate: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Autor:	Heijde, D. van der, Landewe, R.B.M., Mease, P., McInnes, I.B., Conaghan, P.G., Pricop, L., Ligozio, G., Richards, H., Mpofu, S.
Jazyk:	angličtina
Rok vydání:	2014
Zdroj:	Arthritis and Rheumatology, 66, S424-S425
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8efe53923555a609805cfd5f14f52f1d http://hdl.handle.net/1887/100422 Zobrazit plný text záznamu